These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 4637935)
1. The effect of inhibition of catechol O-methyltransferase on some cardiovascular responses to l-dopa in the dog. Robson RD; Antonaccio MJ; Rinehart RK Eur J Pharmacol; 1972 Oct; 20(1):104-8. PubMed ID: 4637935 [No Abstract] [Full Text] [Related]
2. Inhibition of catechol-O-methyl transferase by L-dopa and decarboxylase inhibitors. Baldessarini RJ J Pharm Pharmacol; 1972 Jan; 24(1):78-80. PubMed ID: 4401326 [No Abstract] [Full Text] [Related]
3. Sulfur analogs of dopamine and norepinephrine. Inhibition of catechol-O-methyltransferase. Lutz WB; Creveling CR; Daly JW; Witkop B J Med Chem; 1972 Aug; 15(8):795-802. PubMed ID: 5044295 [No Abstract] [Full Text] [Related]
4. Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase. Engelbrecht I; Petzer JP; Petzer A Cent Nerv Syst Agents Med Chem; 2018; 18(2):115-127. PubMed ID: 29697034 [TBL] [Abstract][Full Text] [Related]
5. Effects of monoamine oxidase and catechol-O-methyltransferase inhibition on dopamine turnover: a PET study with 6-[18F]L-DOPA. Doudet DJ; Chan GL; Holden JE; Pate BD; Morrison KS; Calne DB; Ruth TJ Eur J Pharmacol; 1997 Sep; 334(1):31-8. PubMed ID: 9346324 [TBL] [Abstract][Full Text] [Related]
6. Distribution of catechol-O-methyltransferase, histamine N-methyltransferase and monoamine oxidase in specific areas of the rat brain. Saavedra JM; Brownstein MJ; Palkovits M Brain Res; 1976 Dec; 118(1):152-6. PubMed ID: 990954 [No Abstract] [Full Text] [Related]
7. An investigation of the clinical effect of GPA-1714, a catechol-O-methyl transferase inhibitor. Simpson GM; Varga V J Clin Pharmacol New Drugs; 1972 Oct; 12(10):417-21. PubMed ID: 4561199 [No Abstract] [Full Text] [Related]
8. Effect of chronic L-DOPA administration of catecholamine metabolism in the rat. Lancaster J; Sawyer PR; Shepherd DM; Turnbull MJ Br J Pharmacol; 1973 Apr; 47(4):838-42. PubMed ID: 4723802 [TBL] [Abstract][Full Text] [Related]
9. 6-hydroxydopamine, 6-hydroxydopa and degeneration of adrenergic nerves. de Champlain J; Nadeau R Fed Proc; 1971; 30(3):877-85. PubMed ID: 4324975 [No Abstract] [Full Text] [Related]
10. Inhibition of catechol-O-methyltransferase by N-butyl gallate. Dorris RL; Dill RE Neuropharmacology; 1977 Sep; 16(9):631-4. PubMed ID: 917268 [No Abstract] [Full Text] [Related]
11. Effect of chronic administration of L-dopa on catechol-O-methyltransferase in rat tissues. Sharpless NS; Tyce GM; Owen CA Life Sci I; 1973 Feb; 12(3):97-106. PubMed ID: 4696602 [No Abstract] [Full Text] [Related]
13. Inhibition of human liver catechol-O-methyltransferase by flavonoids. Gugler R; Dengler HJ Naunyn Schmiedebergs Arch Pharmacol; 1973; 276(2):223-33. PubMed ID: 4268471 [No Abstract] [Full Text] [Related]
14. Micro radioisotopic determination of enzymes catechol-O-methyltransferase, phenylethanolamine-N-methyltransferase and monoamine oxidase in a single concentration of tissue homogenate. Parvez H; Parvez S Clin Chim Acta; 1973 Jun; 46(1):85-90. PubMed ID: 4732892 [No Abstract] [Full Text] [Related]
15. The effect of L-dopa on chronotropic responses to cardioaccelerator nerve stimulation in dogs. Whitnack E; Leff A; Mohammed S; Gaffney TE J Pharmacol Exp Ther; 1971 May; 177(2):409-14. PubMed ID: 5568797 [No Abstract] [Full Text] [Related]
16. The effect of various agents on the pressor response to dopa in the anesthetized dog. Pruss TP; McGill JS Eur J Pharmacol; 1969 Oct; 8(1):14-8. PubMed ID: 4391043 [No Abstract] [Full Text] [Related]
17. Beneficial effects of co-administration of catechol-O-methyltransferase inhibitors and L-dihydroxyphenylalanine in rat models of depression. Männistö PT; Lang A; Rauhala P; Vasar E Eur J Pharmacol; 1995 Feb; 274(1-3):229-33. PubMed ID: 7768276 [TBL] [Abstract][Full Text] [Related]
19. Control of the brown fat respiratory response to noradrenaline by catechol-O-methyltransferase. Chinet A; Durand J Biochem Pharmacol; 1979 Apr; 28(8):1353-61. PubMed ID: 444302 [No Abstract] [Full Text] [Related]
20. Reduction of sympathetic outflow by central administration of L-DOPA, dopamine and norepinephrine. Baum T; Shropshire AT Neuropharmacology; 1973 Jan; 12(1):49-56. PubMed ID: 4347064 [No Abstract] [Full Text] [Related] [Next] [New Search]